Emtricitabina Y Tenofovir Alafenamida

Resumen

Alternativas con registro en Colombia

• Lamivudina Y Zidovudina
• Lamivudina Y Abacavir
• Tenofovir Disoproxil Y Emtricitabina
• Abacavir/zidovudina/lamivudina
• Efavirenz. Tenofovir Disoproxil Y Emtricitabina
• Emtricitabina. Tenofovir Disoproxil Y Rilpivirina
• Emtricitabina. Tenofovir Disoproxil. Elvitegravir Y Cobicistat
• Lopinavir Y Ritonavir
• Lamivudina. Tenofovir Disoproxil Y Efavirenz
• Lamidubina. Abacavir Y Dolutegravir
• Darunavir Y Cobicistat
• Elvitegravir. Cobicistat. Emticitabina. Tenofovir Alafenamida

Estudios clínicos principales

• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodia
  Fase 3 · 2015 · 55 participantes · Gilead Sciences · NCT02600819
• Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1
  Fase 2/3 · 2016 · 177 participantes · Gilead Sciences · NCT02881320
• Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
  Fase 3 · 2012 · 872 participantes · Gilead Sciences · NCT01780506 · PubMed 25890673 · PubMed 28282300
• Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
  Fase 3 · 2013 · 872 participantes · Gilead Sciences · NCT01797445 · PubMed 25890673 · PubMed 29627709

Enfermedades relacionadas

• VIH

Fuentes

• Etiqueta FDA (DailyMed): Biktarvy
• EMA: Symtuza
• EMA: Genvoya